CDEK
← All drugs Report issue

nerispirdine

Small moleculeexperimental

Clinical trial activity

3 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Oct 1, 2004 (NCT00093275)

Timeline

2000s

  1. Jan 1, 2004

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CCCN(c1ccncc1F)n1cc(C)c2ccccc21
Mol. weight
283.35 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • hp184
  • hp184
  • hp 184
  • hp-184
  • hp-184
  • hp-184
  • nerispirdine
  • nerispirdine
  • nerispirdine
  • nerispirdine
  • nerispirdine
  • n-(n-propyl)-3-fluoro-4-pyridinyl-1h-3-methylindol-1-amine hydrochloride

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00811902Phase 2Dec 1, 2008Sanofi
NCT00772525Phase 2Sep 1, 2008Sanofi, Thomas Jefferson University
NCT00093275Phase 2Oct 1, 2004Sanofi
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
SanofiFor profit3312004
Thomas Jefferson UniversityAcademic/Hospital1012008
2 organizations
Page 1 / 1